Arm B:Lisaftoclax+homoharringtonine+cytarabine+aclarubicin

2 trials

Sponsors

The FIrst Affiliated Hospital, College of Medicine, Zhejiang University

Conditions

Newly diagnosed intermediate-to-high risk acute myeloid leukemiaNewly diagnosed patients with low-risk acute myeloid leukemia

Unknown Phase

A multicenter, prospective, randomized controlled clinical trial comparing the efficacy of LDA, LHAA, and LA regimens in young adults with intermediate-to-high risk acute myeloid leukemia eligible for intensive chemotherapy.

Active, not recruitingChiCTR2600127904

The FIrst Affiliated Hospital, College of Medicine, Zhejiang UniversityNewly diagnosed intermediate-to-high risk acute myeloid leukemia

Start: 2026-08-01Updated: 2026-07-13

A Multicenter, Prospective, Randomized Controlled Clinical Study Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

Active, not recruitingChiCTR2600128710

The FIrst Affiliated Hospital, College of Medicine, Zhejiang UniversityNewly diagnosed patients with low-risk acute myeloid leukemia

Start: 2026-08-01Updated: 2026-08-03